553 related articles for article (PubMed ID: 32847852)
41. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
42. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.
Huang J; Liao G; Chen H; Wu FY; Hutt-Fletcher L; Hayward GS; Hayward SD
J Virol; 2006 Feb; 80(3):1098-109. PubMed ID: 16414987
[TBL] [Abstract][Full Text] [Related]
43. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
[TBL] [Abstract][Full Text] [Related]
44. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.
Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD
J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of a prediction protocol to identify potential targets of epigenetic reprogramming by the cancer associated Epstein Barr virus.
Flower K; Hellen E; Newport MJ; Jones S; Sinclair AJ
PLoS One; 2010 Feb; 5(2):e9443. PubMed ID: 20195470
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
47. The Epstein-Barr virus LF2 protein inhibits viral replication.
Calderwood MA; Holthaus AM; Johannsen E
J Virol; 2008 Sep; 82(17):8509-19. PubMed ID: 18562535
[TBL] [Abstract][Full Text] [Related]
48. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
49. CpG-methylation regulates a class of Epstein-Barr virus promoters.
Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
[TBL] [Abstract][Full Text] [Related]
50. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
Ellis AL; Wang Z; Yu X; Mertz JE
J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.
Tung CP; Chang FR; Wu YC; Chuang DW; Hunyadi A; Liu ST
J Gen Virol; 2011 Aug; 92(Pt 8):1760-1768. PubMed ID: 21490247
[TBL] [Abstract][Full Text] [Related]
52. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.
Liu P; Speck SH
Virology; 2003 Jun; 310(2):199-206. PubMed ID: 12781707
[TBL] [Abstract][Full Text] [Related]
53. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
[TBL] [Abstract][Full Text] [Related]
54. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
55. Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle.
Guo Q; Qian L; Guo L; Shi M; Chen C; Lv X; Yu M; Hu M; Jiang G; Guo N
Mol Immunol; 2010 May; 47(9):1783-92. PubMed ID: 20338640
[TBL] [Abstract][Full Text] [Related]
56. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
Cox MA; Leahy J; Hardwick JM
J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
[TBL] [Abstract][Full Text] [Related]
57. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
Robinson AR; Kwek SS; Kenney SC
PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751
[TBL] [Abstract][Full Text] [Related]
58. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
Flemington EK; Lytle JP; Cayrol C; Borras AM; Speck SH
Mol Cell Biol; 1994 May; 14(5):3041-52. PubMed ID: 8164660
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE
PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871
[TBL] [Abstract][Full Text] [Related]
60. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
